Antiviral activity of rosemary extract against Zika virus in human dermal fibroblasts
Masi, J. T.; Crozier, R. W. E.; Coish, J. M.; Hicks, N. J.; Tsiani, E.; Patterson, E. I.; MacNeil, A. J.
Show abstract
Flaviviruses have increasingly emerged and re-emerged in recent decades, infecting millions of people annually. Zika virus (ZIKV) is particularly concerning due to its associated pathological complications, including microcephaly in newborns and Guillain-Barre syndrome in adults, posing a significant threat to public health. Despite efforts made by the scientific community, no licensed drugs against flaviviruses have been developed. Medicinal plants show promise as a novel source of antiviral agents, as they possess a diverse array of biologically active secondary metabolites, making them potential candidates for therapeutic use. Here, we sought to investigate the antiviral potential of rosemary extract (RE) against ZIKV in human dermal fibroblasts (HFF-1), one of the earliest cellular targets of infection. ZIKV was treated with various concentrations of RE or its major polyphenols, including rosmarinic acid (RA), carnosic acid (CA), and carnosol (CO), and the infectivity of each sample was measured by plaque reduction assay. To evaluate the impact of RE on different stages of the ZIKV replication cycle, HFF-1 cells were treated before, during, and after infection, or the virus was treated before infection. RE exerted potent virucidal activity against ZIKV in both Vero and HFF-1 cells by directly acting on virus particles before infection. Importantly, RE significantly inhibited the later stages of the virus replication cycle by interfering with post-entry mechanisms within the host cell. Moreover, major RE-derived polyphenols CA and CO, but not RA, were shown to significantly reduce infectivity when ZIKV was pre-treated with each compound individually. Overall, RE significantly impairs ZIKV infection in vitro by directly interacting with virus particles prior to adsorption and interfering with post-entry processes of the viral replication cycle. This study highlights the antiviral potential of RE and its individual components, wFigurearranting further investigation into the mechanisms underlying their activity and their effects on other medically important flaviviruses.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo 96%
- Assessing Human Liver Spheroids as a Model for Antiviral Drug Evaluation Against BSL-3 Haemorrhagic Fever viruses 95%
- Identification of novel Ebola virus inhibitors using biologically contained virus 94%
Similar papers in this journal
- A photoactivable natural product with broad antiviral activity against enveloped viruses including highly pathogenic coronaviruses 96%
- Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production 96%
- Selective estrogen receptor modulators limit alphavirus infection by targeting the viral capping enzyme nsP1 96%
Similar papers in this journal
- Replication of Equine arteritis virus is efficiently suppressed by purine and pyrimidine biosynthesis inhibitors 96%
- Antiviral activity of lambda-carrageenan against influenza viruses in mice and severe acute respiratory syndrome coronavirus 2 in vitro 95%
- Methylene Blue has a potent antiviral activity against SARS-CoV-2 in the absence of UV-activation in vitro 94%
Similar papers in this journal
- Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture 95%
- Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2 94%
- Inhibitors of L-type calcium channels show therapeutic potential for treating SARS-CoV-2 infections by preventing virus entry and spread 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.